Your browser doesn't support javascript.
loading
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.
Lickliter, Jason D; Voskoboynik, Mark; Mileshkin, Linda; Gan, Hui K; Kichenadasse, Ganessan; Zhang, Kathy; Zhang, Maggie; Tang, Zhiyu; Millward, Michael.
Afiliação
  • Lickliter JD; Nucleus Network, Melbourne, VIC, Australia.
  • Voskoboynik M; Nucleus Network, Melbourne, VIC, Australia.
  • Mileshkin L; Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Gan HK; Peter MacCallum Cancer Centre-East Melbourne, East Melbourne, VIC, Australia.
  • Kichenadasse G; Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, Heidelberg, Melbourne, VIC, Australia.
  • Zhang K; La Trobe University School of Cancer Medicine, Heidelberg, VIC, Australia.
  • Zhang M; Department of Medicine, University of Melbourne, Heidelberg, VIC, Australia.
  • Tang Z; Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, SA, Australia.
  • Millward M; BeiGene USA, Inc., San Mateo, CA, USA.
Br J Cancer ; 126(4): 576-585, 2022 03.
Article em En | MEDLINE | ID: mdl-34795408
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluorenos / Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluorenos / Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article